E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E

Ming Li1, Ling Ouyang2, Zhigang Zheng3

  • 1Department of Hepatobiliary Pancreas and Vessel Surgery, Chenggong Hospital of Xiamen University, Xiamen, Fujian, P.R. China.

Oncology Reports
|February 11, 2017
PubMed

Insights

F-box and WD repeat domain-containing 7 (FBW7) acts as a tumor suppressor in cholangiocarcinoma (CCA) by inhibiting cell proliferation. Targeting its substrate c-Myc may offer a new therapeutic strategy for CCA treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • F-box and WD repeat domain-containing 7 (FBW7) is a crucial tumor suppressor targeting oncoproteins for degradation.
  • FBW7 mutations are common in human cancers, but its role in cholangiocarcinoma (CCA) is not well understood.

Purpose of the Study:

  • To investigate the function of FBW7 in cholangiocarcinoma (CCA) cell proliferation and tumor growth.
  • To identify FBW7 targets involved in CCA progression.

Main Methods:

  • Overexpression of FBW7α in CCA cells.
  • Assessment of cell cycle progression and proliferation in vitro.
  • Evaluation of CCA xenograft tumor growth in vivo.
  • Analysis of c-Myc and cyclin E protein levels.

Main Results:

  • FBW7α overexpression induced G1 cell cycle arrest and inhibited CCA cell proliferation and xenograft tumor growth.
  • FBW7α overexpression led to the degradation of c-Myc and cyclin E.
  • Restoring c-Myc, but not cyclin E, rescued proliferation in FBW7α-overexpressing CCA cells.

Conclusions:

  • FBW7α functions as a tumor suppressor in CCA progression.
  • FBW7α inhibits CCA by degrading c-Myc and cyclin E.
  • Targeting FBW7α substrate c-Myc presents a potential therapeutic strategy for CCA.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K